Fundraising FoxBetter Therapeutics
San Francisco, US · Founded 2020 · Delaware corporation
Find your way into Better Therapeutics
Sign up to see every warm intro you have to Better Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Better Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Better Therapeutics was founded in 2020 by Kristin Wynholds.
MH
Mark HeinenChief Financial Officer2021–2023Mark Heinen has served as CFO at multiple technology, SaaS, digital health, and aviation companies, with 30+ years of finance leadership experience including capital markets transactions, public company transformations, and M&A. His expertise includes deSPAC transactions, reverse mergers, venture debt structuring, and SOX compliance frameworks.
AA
Andrew ArmaninoNamed on SEC filing
GP
Geoffrey ParkerNamed on SEC filing
MB
Mark BermanNamed on SEC filing
DP
David PerryNamed on SEC filing
Board
RC
Richard CarmonaBoard director
RL
Risa Lavizzo-MoureyBoard director
EG
Elder GrangerBoard director
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 3 rounds · 2023–2024
▶$250KraisedJan 2024 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJan 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elder GrangerDirector
- Richard CarmonaDirector
- Risa Lavizzo-MoureyDirector
- David PerryExecutive Officer, Director
- Kristin WynholdsExecutive Officer
- Geoffrey ParkerDirector
- Frank KarbeExecutive Officer, Director
- Andrew ArmaninoDirector
- Mark BermanExecutive Officer
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.1MraisedAug 2023 · 10 investors · BiotechnologyRule 506(b)
▶$2.1MraisedAug 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elder GrangerDirector
- Frank KarbeExecutive Officer, Director
- David PerryExecutive Officer, Director
- Kristin WynholdsExecutive Officer
- Risa Lavizzo-MoureyDirector
- Geoffrey ParkerDirector
- Mark HeinenExecutive Officer
- Mark BermanExecutive Officer
- Andrew ArmaninoDirector
- Richard CarmonaDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Sales commissions
- $126.9K
- Placement agents
- Titan Partners Group LLC, a division of American Capital Partners, LLC, Chardan Capital Markets LLC
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$6.5MraisedApr 2023 · 9 investors · BiotechnologyRule 506(b)
▶$6.5MraisedApr 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank KarbeExecutive Officer, Director
- Andrew ArmaninoDirector
- Geoffrey ParkerDirector
- Richard CarmonaDirector
- Mark HeinenExecutive Officer
- Mark BermanExecutive Officer
- Risa Lavizzo-MoureyDirector
- Elder GrangerDirector
- David PerryExecutive Officer, Director
- Kristin WynholdsExecutive Officer
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- Sales commissions
- $325K
- Placement agents
- Chardan Capital Markets LLC, Brookline Capital Markets, a division of Arcadia Securities, LLC
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Better Therapeutics?
- Better Therapeutics was founded by Kristin Wynholds in 2020.
- How much funding has Better Therapeutics raised?
- Better Therapeutics has disclosed $8.9M raised across 3 rounds.
- Where is Better Therapeutics headquartered?
- Better Therapeutics is headquartered in San Francisco, US.